Risks of Compounded Semaglutide from Pharmacies

The Rise in Popularity of Compounded Semaglutide

Semaglutide, sold under the brand names Ozempic and Wegovy, has become an increasingly popular prescription medication used to treat type 2 diabetes and chronic weight management. As demand has grown rapidly, many patients have turned to compounding pharmacies to fill their semaglutide prescriptions.

What is a Compounding Pharmacy?

Compounding pharmacies mix customized medications on a small scale to meet individual patient needs. For example, they may alter doses, change delivery methods (like creating a topical gel out of an oral medication), or make medication without specific fillers or dyes per a patient's request.

Because the FDA does not verify the safety or efficacy of compounded drugs, it technically labels them as "essentially copies" of the original approved drug. This means the pharmacies selling compounded semaglutide do not have the rigorous randomized controlled trial data that the branded versions underwent for FDA approval.

Why Patients Seek Compounded Semaglutide

There are a few key reasons why patients may seek compounded semaglutide instead of the branded version:

• Cost - Compounding pharmacies typically do not accept insurance, but their cash pay prices for semaglutide may be cheaper than some patients' copays for Ozempic or Wegovy.
• Convenience - Seeing an increase in demand, some compounding pharmacies now offer online services, telehealth consultations, and mail delivery to increase access and convenience for patients.
• Different doses - Compounding allows pharmacists to produce doses of semaglutide that differ from the standard 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg versions available in branded vials and pens. This appeals to some patients seeking more precision with their dosing.
• Scarcity - Due to incredible demand, there have been notable shortages of Ozempic and Wegovy. Compounding offers patients a way to still obtain semaglutide even when the branded versions are unavailable locally.

The FDA's Stance on Compounded Semaglutide

In recent years, various compounding pharmacies across the country began offering their own forms of compounded semaglutide to meet surging patient interest. However, in 2022 the FDA began cracking down with serious concerns about the safety of compounded semaglutide products.

Lack of Rigorous Testing

The FDA emphasized that the branded semaglutide products went through extensive clinical trials to prove safe and effective for treating type 2 diabetes and obesity. More than 9,000 people participated in randomized control trials lasting 2+ years before FDA approval.

Compounding pharmacies essentially replicate semaglutide without all the proprietary inactive ingredients used in Ozempic and Wegovy. Their products do not undergo rigorous third party testing to ensure correct dosing, consistent absorption, or even product purity.

Risk of Contamination

One of the FDA's biggest worries is potential contamination of compounded injectable drugs like semaglutide. If facilities have poor safety protocols, compounded formulations could easily become tainted with life-threatening bacteria or chemicals.

For example, in 2019 several patients died and others suffered severe joint and muscle pain after receiving compounded injections contaminated with mold.

Concerns Over Misuse

Some compounding pharmacies offering semaglutide promote medical loopholes like telehealth consultations with an out-of-state provider to bypass more stringent in-person requirements. This raises alarms for the prescription to be misused or overprescribed.

The FDA already placed semaglutide products under a REMS (Risk Evaluation and Mitigation Strategy) given worries that the GLP-1 drug class carries risks like thyroid cancer or pancreatitis. So oversight on proper prescribing is extremely important.

Key Safety Risks of Compounded Semaglutide

While patients may opt for compounded versions to save on costs, the FDA emphasized that safety should be the top priority. There are genuine risks involved with using an essentially untested product.

Inconsistent Dosing

Even slight deviations in dosing can impact efficacy and side effects. For example, going from 1.0mg to 1.2mg could increase GI events or dulled appetite suppression at higher doses. But compounding does not undergo analysis to confirm precision.

Purity Issues

Small independent pharmacies likely do not have extensive quality control measures that pharmaceutical giants like Novo Nordisk do. So bacterial growth, dangerous fillers, or inactive ingredient issues become more likely.

Adulterated Ingredients

GLP-1 drugs require careful transport and storage at 36 to 46F to remain stable. Compounding pharmacies may cut corners on cold storage or let products sit at unsafe temperatures during shipping. This could essentially adulterate or degrade the compounded semaglutide before injection.

Loss of Efficacy

Even with precise dosing, contamination risks mean compounded semaglutide could have less efficacy treating diabetes or obesity. Patients may not get the A1c or weight loss results anticipated, while still assuming all the other side effect risks.

Exercising Caution Moving Forward

The FDA crackdown on compounding pharmacies aims to keep patients safe, but it also eliminated access to more affordable semaglutide for some. Patients still interested should exercise extreme caution.

Research the Pharmacy Thoroughly

Scrutinize any compounding pharmacy offering semaglutide. Do they hold all proper licensure for your state? Do they have a track record of quality and safety complaints? What protocols are in place to ensure purity and dosing accuracy?

Talk to Your Doctor First

Never start compounded semaglutide without guidance from your prescribing physician. Make them aware of the risks the FDA highlighted so you can determine if it is right for your situation.

Start Low and Go Slow

When trying compounded semaglutide for the first time, be very conservative with dosing increases to gauge how your body responds. This minimizes side effect severity if the product has issues.

Inform your doctor at the first sign of anything unexpected - whether side effects or lack of therapeutic benefit. Stop usage immediately until you can investigate with the compounding pharmacy.

Ultimately semaglutide remains an incredibly beneficial medication for many people with obesity or diabetes when prescribed properly. But bypassing regulatory safeguards does involve genuine risks that consumers should weigh carefully. Discuss all options with your doctor to make the most informed decision for your health.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new treatment regimen.